GlassScriptPhysician profile
Daniel Max Mollengarden
NPI 1841619152
$5,550.61
in general payments reported to CMS, 2019-2025
35 companies · $532 in 2025
The $532 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $303 · 2021: $208 · 2022: $382 · 2023: $2,619 · 2024: $1,253 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,694 · Travel and Lodging: $1,675 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,693.61 |
| Travel and Lodging | $1,674.90 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,932.76 | 2020-2025 | Moses 550 D\F\L, Lumenis Pulse 120h, Lithovue |
| Procept Biorobotics Corporation | $292.00 | 2023 | Aquabeam Robotic System |
| Dendreon Pharmaceuticals LLC | $193.39 | 2019-2024 | Provenge |
| Laborie Medical Technologies Corp. | $164.43 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Teleflex LLC | $163.19 | 2023 | Urolift |
| Astellas Pharma US INC | $145.59 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $136.81 | 2023-2024 | Welireg, Keytruda, Lynparza |
| Ferring Pharmaceuticals INC. | $131.18 | 2024-2025 | Adstiladrin |
| Myovant Sciences INC. | $129.85 | 2022 | |
| Sumitomo Pharma America, INC. | $126.96 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $120.73 | 2022-2025 | Erleada |
| Medtronic, INC. | $98.02 | 2024-2025 | Interstim |
| Endo USA, INC. | $96.91 | 2024-2025 | Xiaflex, Aveed |
| Ethicon US, LLC | $91.16 | 2020 | |
| Edap Technomed INC | $72.00 | 2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $70.41 | 2025 | Cvac Aspiration System |
| Stryker Corporation | $68.00 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $61.68 | 2022-2024 | Bard Urinary Drainage Bag |
| Bayer Healthcare Pharmaceuticals INC. | $54.41 | 2023 | |
| Ambu INC. | $47.75 | 2021-2024 | |
| Innovation Technologies INC | $38.74 | 2024-2025 | Irrisept |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Myriad Genetic Laboratories, INC. | $31.49 | 2024 | Prolaris |
| Becton, Dickinson and Company | $29.29 | 2023 | Bard Urinary Drainage Bag |
| Pfizer INC. | $28.49 | 2024 | |
| Civco Medical Instruments | $23.36 | 2025 | |
| Antares Pharma, INC. | $22.95 | 2024 | Xyosted |
| Karl Storz Endoscopy-America | $21.45 | 2022 | |
| Agiliti Surgical, INC. | $21.26 | 2023 | Sonablate, Trinity, Soltive |
| Abbvie INC. | $19.41 | 2024 | |
| Smith+Nephew, INC. | $19.03 | 2025 | Stravix |
| Hollister Incorporated | $18.86 | 2022 | |
| Endo Pharmaceuticals INC. | $15.57 | 2020 | |
| Rochester Medical Corporation | $15.13 | 2019 | |
| Srs Medical Systems, INC. | $13.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Mollengarden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.